Zenith Takes $200 Mil. Schering-Plough Account

LOS ANGELES—Zenith Media in New York was assigned the $200 million Schering-Plough Corp. media planning and buying business last week without a review, the client confirmed. Incumbent Lowe Lintas & Partners in New York continues to handle the drug maker’s creative account. Schering’s media is primarily spent on its blockbuster anti allergy drugs, Claritin and Nasonex.

Gillette Readies $150 Mil.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in